The concept of leveraging the immune system for the treatment of disease emerged in the mid-20th century, facilitated by the discovery of molecules involved in immune surveillance. By the late 1990s researchers understood the role of regulatory molecules such as CTLA-4, PD-1, and PD-L1 in limiting T-cell activity, which cancer cells exploit to evade detection.
verifiedCite
While every effort has been made to follow citation style rules, there may be some discrepancies.
Please refer to the appropriate style manual or other sources if you have any questions.
Select Citation Style